COMMUNIQUÉS West-GlobeNewswire

Orphazyme completes enrollment in phase 3 trial evaluating arimoclomol in Amyotrophic Lateral Sclerosis
18/07/2019
Orphazyme A/S Company announcement No. 17/2019 Company Registration No. 32266355 • Headline results from full analysis expected in H1 2021 Copenhagen, Denmark, July 18, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a [...]
ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
18/07/2019
Geneva, Switzerland and Boston, MA – July 18, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]
Pixium Vision announced sustained success of its PRIMA System after 12-months in dry age-related macular degeneration patients
18/07/2019
Data confirm better than expected interim six-month results The system is sustainably well tolerated while preserving residual peripheral vision Some patients improve their ability to identify letters and sequence of [...]
Pixium Vision confirme les bons résultats cliniques de son système Prima après 12 mois chez des patients atteints de DMLA sèche
18/07/2019
Les données renforcent les résultats intermédiaires meilleurs qu’attendus à 6 mois Le système est toujours bien toléré et sans impact sur la vision périphérique résiduelle Plusieurs patients améliorent leur capacité à [...]
Acacia Pharma Founder Dr. Julian Gilbert steps down - Michael Bolinder, Chief Commercial Officer, becomes CEO in Planned Succession
18/07/2019
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and Indianapolis, US – 18 July 2019: Acacia Pharma Group plc (“Acacia Pharma”, [...]
Fulcrum Therapeutics Announces Pricing of Initial Public Offering
18/07/2019
CAMBRIDGE, Mass., July 17, 2019 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (the “Company”) (Nasdaq:FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically [...]
Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States
18/07/2019
Company Announcement Genmab has today announced the pricing of its initial public offering of ADSs and the listing of the ADSs on the Nasdaq Global Select Market under the symbol “GMAB” Genmab has applied to change the [...]
Forty Seven, Inc. Prices Underwritten Public Offering of 9,375,000 Shares of Common Stock
18/07/2019
MENLO PARK, Calif., July 17, 2019 (GLOBE NEWSWIRE) -- Forty Seven, Inc. (Nasdaq: FTSV), a clinical stage immuno-oncology company, today announced the pricing of its previously announced underwritten public offering of 9 [...]
H-CYTE Comments on Recent Promotional Activity
17/07/2019
TAMPA, Fla., July 17, 2019 (GLOBE NEWSWIRE) -- H-CYTE, INC. (OTCQB: HCYT), wishes to make, at the request of the OTC Markets Group Inc., the following release regarding certain market activity surrounding the Company's [...]
Innovate Phytotechnologies Inc. Hemp for Life(TM) Products Hit the Market in America
17/07/2019
VANCOUVER, B.C. and KELOWNA, B.C., July 17, 2019 (GLOBE NEWSWIRE) -- Innovate Phytotechnologies Inc., through its wholly owned subsidiary, Phytomatrix Natural Technologies Inc., (“Phytomatrix”) is pleased to announce [...]
Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/07/2019
WALTHAM, Mass., July 17, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:RDUS) today announced that the Compensation Committee of the Company’s Board of Directors granted a new employee [...]
AzurRx BioPharma Announces Proposed Public Offering of Common Stock
17/07/2019
BROOKLYN, N.Y., July 17, 2019 (GLOBE NEWSWIRE) -- AzurRx BioPharma (NASDAQ: AZRX), (“AzurRx” or the “Company”), announced today that it intends to offer and sell shares of its common stock in an underwritten public [...]
Micron Solutions, Inc. Hires New CFO
17/07/2019
FITCHBURG, Mass., July 17, 2019 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]
Assertio Therapeutics to Report Second Quarter 2019 Financial Results After The Close of Markets on Wednesday, August 7, 2019
17/07/2019
LAKE FOREST, Ill., July 17, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release second quarter 2019 financial results on Wednesday, August 7, 2019, after the close of [...]
TransMedics to Report Second Quarter 2019 Financial Results on August 7, 2019
17/07/2019
ANDOVER, Mass., July 17, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, [...]
Delcath Systems Closes $20 Million Private Placement
17/07/2019
NEW YORK, July 17, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (OTCPK: DCTH) has closed on its previously announced private placement with gross proceeds of $20 million [...]
Rhythm Pharmaceuticals Launches Free Genetic Testing Program for Rare Genetic Disorders of Obesity
17/07/2019
-- Uncovering Rare Obesity program may help determine underlying cause of severe obesity -- -- Program increases access to genetic testing to improve diagnosis of rare genetic disorders of obesity -- BOSTON, July 17, [...]
MacroGenics Provides Update on Flotetuzumab Program in Acute Myeloid Leukemia
17/07/2019
Enrollment of Phase 1 monotherapy expansion cohort completed; presentation of data expected 2H2019 End of Phase 1 meeting requested with FDA to discuss program and future development plans Initiation of enrollment of [...]
Amarin Announces $400,000,000 Public Offering of American Depositary Shares
17/07/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, July 17, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that it has commenced an underwritten public offering of $400,000,000 of its American [...]

Pages